Diabetic neuropathy: clinical features and contemporary possibilities of diagnostics and treatment

Czech version

Authors: Milan Grofik; Egon Kurča
Authors‘ workplace: Neurologická klinika Jesseniovej lekárskej fakulty UK a Univerzitná nemocnica Martin, prednosta prof. MUDr. Egon Kurča, PhD.
Published in: Forum Diab 2013; 2(2): 108-116
Category:

Overview

Patients with diabetes mellitus are at risk of developing a variety of complications, and a large part of their are associated directly or indirectly to the peripheral and / or central nervous system. The objective of this work is to acquaint readers with a variety of potential complications in the peripheral nervous system associated with diabetes mellitus. The thesis describes in detail the relative clinical features of different types and forms of neuropathy, including diagnosis and new diagnostic methods for detection of neuropathy. Thesis gives an overview of the recommendations recently for the treatment of diabetic neuropathy.

Key words:
autonomic neuropathy – complications – diabetes mellitus – peripheral neuropathy

Sources

1. Boulton AJ, Vinik AI, Arezzo JC et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28(4): 956–962.

2. Dyck PJ, Melton LJ, O´Brien PC et al. Approaches to improve epidemiological studies of diabetic neuropathy. Diabetes 1997; 46(S2): S5-S8.

3. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2003. Rev ed. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2004. Dostupné z WWW: <http://www.cdc.gov/diabetes>.

4. Tesfaye S. Diabetic neuropathy. In: Wass JAH et al. Oxford Textbook of Endokrinology and Diabetes 2002: 1789–1798.

5. Callaghan BC, Hur J, Feldman EL. Diabetic neuropathy. Curr Opin Neurol 2012; 25(5): 536–541.

6. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2011. Dostupné z WWW: <http://www.cdc.gov/diabetes>.

7. Shakher J, Stevens MJ. Update on the management of diabetic polyneuropathies. Diabetes, Metabolic Syndrome and Obesity. Targes and Therapy 2011. Diabetes Metab Syndr Obes 2011; 4: 289–305.

8. Papanas N, Ziegler D. Prediabetic Neuropathy: Does It Exist? Curr Diab Rep 2012; 12(4): 376–383.

9. Daousi C, Benbow SJ, Woodward A et al. The natural history of chronic painful peripheral neuropathy in a community diabetes population. Diabet Med 2006; 23(9): 1021–1024.

10. Davies M, Brophy S, Williams R et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006; 29(7): 1518–1522.

11. Ziegler D, Rathmann W, Dickhaus T (eds) et al. KORA Study Group. Neuropathic pain in diabetes, pre-diabetes and normal glucose tolerance:the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med 2009; 10(2): 393–400.

12. Ziegler D, Rathmann W, Meisinger C(eds) et al. KORA Study Group. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA myocardial infarction registry. Eur J Pain 2009; 13(6):582–587.

13. Daousi C, MacFarlane IA, Woodward A et al. Chronic painful peripheral neuropathy in an urban community: a controlles comparison of people with and without diabetes. Diabetic Medicine 2004; 21(9): 976–982.

14. Treede RD, Jensen TS, Campbell JN et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008; 70(18): 1630–1635.

15. Tentolouris N, Marinou K, Kokotis P et al. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med 2009; 26(3): 302–305.

16. Mokáň M. Fenomén neuvedomovania si hypoglykémie. In: Krahulec B. Diabetická polyneuropatia II. Arimes, Bratislava 2002: 120–131.

17. Abbott CA, Vileikyte L, Williamson S et al. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 1998; 21(7): 1071–1075.

18. Opavský J. Autonomní nervový systém a diabetická autonomní neuropatie. Klinické aspekty a diagnostika. Galén: Praha 2002. ISBN 8072621947.

19. Rušavý Z et al. Diagnostika a klasifikace diabetické neuropatie. In: Diabetická neuropatie. Konsensuální konference. Žinkovy, 20.–22. března 1997. Galén: Praha 1998. ISBN 8085824728.

20. Papanas N, Papatheodorou K, Christakidis D et al. Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes 2005; 113(4): 195–198.

21. Malik RA, Tesfaye S, Newrick PG et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005; 48(3): 578–585.

22. Lauria G, Hsieh ST, Johansson O et al. European Federation of Neurological Societies; Peripheral Nerve Society. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010; 17(7): 356–363.

23. Lauria G, Bakkers M, Schmitz C et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 2010; 15(3): 202–207.

24. Quattrini C, Tavakoli M, Jeziorska M et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 2007; 56(8): 2148–2154.

25. Tavakoli M, Quattrini C, Abbott C et al. Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 2010; 33(8): 1792–1797.

26. Tesfaye S, Boulton AJ, Dyck PJ et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33(10): 2285–2293.

27. Ziegler D. Current Concepts in the Management of Diabetic Polyneuropathy. Curr Diabetes Rev 2011; 7(3): 208–220.

28. Shakher J, Stevens MJ. Update on the management of diabetic polyneuropathies. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011; 4: 289–305.

29. Ziegler D, Nowak H, Kempler P et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpa-lipoic acid: a meta-analysis. Diabet Med 2004; 21(4): 114–121.

30. Ziegler D, Ametov A, Barinov A et al. Oral treatment with alphalipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006; 29(11): 2365–2370.

31. Ziegler D, Hanefeld M, Ruhnau KJ et al. The ALADIN III Study Group. Treatment of Symptomatic Diabetic Polyneuropathy with the Antioxidant alfa-Lipoic Acid. Diabetes Care 1999; 22(8): 1296–1301.

32. Stracke H, Gaus W, Achenbach U et al. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Exp Clin Endocrinol Diabetes 2008; 116(10): 600–605.

33. Ziegler D, Movsesyan L, Mankovsky B et al. Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients. Diabetes Care 2009; 32(8): 1479–1484.

34. Daousi C, Benbow SJ, Woodward A et al. The natural history of chronic painful peripheral neuropathy in a community diabetes population. Diabet Med 2006; 23(9): 1021–1024.

35. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150(3): 573–581.

36. Kajdasz DK, Iyengar S, Desaiah D et al. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. Clin Ther 2007; 29(Suppl): 2536–2546.

37. Freeman R, Durso-Decruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care 2008; 31(7): 1448–1454.

38. Mason L, Moore RA, Derry S et al. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004; 328(7446): 991–995.